IMED PHARMA LIMITED

Imed Pharma Limited (trading as iMed Healthcare) is a leading pharmaceutical wholesaler that supplies parallel-imported branded medicines, generics and over-the-counter products across the Northern Ireland, UK and Republic of Ireland markets. By combining strong global partnerships with strategic placement and supply-chain innovation, iMed provides customers with the right product at the right price and the right time, while maintaining full compliance with the FMD and operating under GMP and GDP-licensed premises.

The company's portfolio spans branded medicines, diagnostics, high-tech devices, OTCs, generics, unlicensed medicines (ULMs) and nutritional products. A custom-built manufacturing facility in Northern Ireland enables the release of almost 500,000 units each month, ensuring a reliable flow of quality medicines to pharmacies, hospitals and healthcare providers. iMed's dedicated regulatory, sales, purchasing and warehouse teams work closely with manufacturers, frontline wholesalers, the HSE, HPRA, IMVO, IPU Hospital Pharmacy and IQVIA, fostering long-term trust and growth.

Rooted in core values of responsibility, trust, healthcare innovation and community, iMed invests in local employment and promotes family-centred values, aiming to improve healthcare outcomes throughout the island. The business operates from offices in both Northern Ireland and the Republic of Ireland, serving a broad network of clients across the region.